Evidence map›Paper›PMID 16924490›Full record

ArticleImmunogenetics2006

Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.

Junzo Norimine, Sushan Han, Wendy C Brown

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Identification of a DRB3*011:01-restricted CD4Frontiers in immunology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junzo NorimineDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040, USA. nori@vetmed.wsu.edu
Sushan Han
Wendy C Brown

Funding

Infectious Diseases and Microbial Immunology Training ProgramT32AI007025 · NIAID · WASHINGTON STATE UNIVERSITY · PI Thomas H KAWULA, M KARIUKI NJENGA · 1985 to 2026
$7.4M
Immunogenicity of the Type IV Secretin SystemR01AI053692 · NIAID · WASHINGTON STATE UNIVERSITY · PI BROWN, WENDY CATHERINE · 2003 to 2012
$3.3M
Antigenic variation in rickettsial transmissionR01AI044005 · NIAID · WASHINGTON STATE UNIVERSITY · PI PALMER, GUY HUGHES · 1999 to 2008
$2.4M
NIAID NIH HHS R01-AI053692NIAID NIH HHS R01-AI44005NIAID NIH HHS T32 AI007025
6 · The paper itself

Abstract

Antigen-specific CD4+ T cells play a critical role in protective immunity to many infectious pathogens. Although the antigen-specific CD4+ T cells can be measured by functional assays such as proliferation or cytokine enzyme-linked immunospot, such assays are limited to a specific function and cannot quantify anergic or suppressed T cells. In contrast, major histocompatiblity complex (MHC) class II tetramers can enumerate epitope-specific CD4+ T cells independent of function. In this paper, we report the construction of bovine leukocyte antigen MHC class II tetramers using a novel mammalian cell system to express soluble class II DRA/DRB3 molecules and defined immunodominant peptide epitopes of Anaplasma marginale major surface proteins (MSPs). Phycoerythrin-labeled tetramers were either loaded with exogenous peptide or constructed with the peptide epitope linked to the N terminus of the DRB3 chain. A DRB3*1101 tetramer loaded with MSP1a peptide F2-5B (ARSVLETLAGHVDALG) and DRB3*1201 tetramers loaded with MSP1a peptide F2-1-1b (GEGYATYLAQAFA) or MSP2 peptide P16-7 (NFAYFGGELGVRFAF) specifically stained antigen-specific CD4+ T cell lines and clones. Tetramers constructed with the T-cell epitope linked to the DRB3 chain were slightly better at labeling CD4+ T cells. In one cell line, the number of tetramer-positive T cells increased to approximately 94% of the CD4+ T cells after culture for 21 weeks with specific antigen. This novel technology should be useful to track the fate of antigen-specific CD4+ T-cell responses in cattle after immunization or infection with persistent pathogens, such as A. marginale, that modulate the host immune response.

Indexed as

Amino Acid SequenceAnaplasma marginaleAnimalsAntigens, BacterialBacterial Outer Membrane ProteinsBase SequenceCattleCD4-Positive T-LymphocytesCell LineDNAErythrocytesGenes, MHC Class IIHistocompatibility Antigens Class IIImmunodominant EpitopesIn Vitro TechniquesMolecular Sequence DataAntigens, BacterialBacterial Outer Membrane ProteinsBoLA-DRB3 antigenDNAHistocompatibility Antigens Class IIImmunodominant Epitopesmajor surface protein 1a, Anaplasmamsp2 protein, Anaplasma marginale

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.